Orphan G protein-coupled receptors in the CNS

Current Opinion in Pharmacology

Volumn 1, Issue 1, 2001, Pages 31-39

  Lee, Dennis K ^a   George, Susan R ^a,b   O'Dowd, Brian F ^a,b   Evans, Jilly F ^c   Lynch, Kevin R ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Endopgenous ligand; Expression; Homology; Mammalian; Reverse Pharmacology

Indexed keywords

ANGIOTENSIN RECEPTOR; CANNABINOID RECEPTOR; CELL SURFACE RECEPTOR; DRUG RECEPTOR; GALANIN RECEPTOR; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y RECEPTOR; SOMATOSTATIN RECEPTOR;

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; RECEPTORS, ANGIOTENSIN; RECEPTORS, CANNABINOID; RECEPTORS, CELL SURFACE; RECEPTORS, DRUG; RECEPTORS, GALANIN; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, SOMATOSTATIN;

EID: 0035260321     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00003-0     Document Type: Review

References (50)

1. Marchese A, George SR, Kolakowski LF Jr, Lynch KR, O'Dowd BF. Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology. Trends Pharmacol Sci. 20:1999;370-375.
2. Saito Y, Nothacker H, Civelli O. Melanin-concentrating hormone receptor: An orphan receptor fits the key. Trends Endocrinol Metab. 11:2000;299-303.
3. Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, Maratos-Flier E. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol. 274:1998;E627-E633.
4. Tritos NA, Maratos-Flier E. Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone. Neuropeptides. 33:1999;339-349.
5. Nothacker HP, Wang Z, McNeill AM, Saito Y, Merten S, O'Dowd B, Duckles SP, Civelli O. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol. 1:1999;383-385. This paper details the discovery of the endogenous ligand for the GPR14 receptor, U-II. Interestingly, the ligand was discovered by both tissue extraction reverse pharmacology and deduced identity through similar biochemical structure with somatostatin. Furthermore, somatostatin and cortistatin both displayed activity on GPR14, although with low efficacy.
6. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DL Jr, Davidoff M, Wang R, Austin CP, McDonald TP, et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun. 266:1999;174-178.
7. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 401:1999;282-286.
8. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, Kitada C, Kikuchi K, Shintani Y, Kurokawa T, Onda H, et al. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun. 265:1999;123-129.
9. Lee DK, Nguyen T, Porter CA, Cheng R, George SR, O'Dowd BF. Two related G protein-coupled receptors: the distribution of GPR7 in rat brain and the absence of GPR8 in rodents. Brain Res Mol Brain Res. 71:1999;96-103.
10. Matsumoto M, Kamohara M, Sugimoto T, Hidaka K, Takasaki J, Saito T, Okada M, Yamaguchi T, Furuichi K. The novel G-protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin receptors. Gene. 248:2000;183-189.
11. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O'Dowd BF. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 74:2000;34-41. Observing similarities in sequence and distribution, the authors hypothesized shared physiological roles between apelin and angiotensin II. Subsequently, apelin administration revealed effects in lowering blood pressure and increased drinking behaviour.
12. Choe W, Albright A, Sulcove J, Jaffer S, Hesselgesser J, Lavi E, Crino P, Kolson DL. Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. J Neurovirol. 6:(suppl 1):2000;S61-S69.
13. Hinuma S, Onda H, Fujino M. The quest for novel bioactive peptides utilizing orphan seven-transmembrane-domain receptors. J Mol Med. 77:1999;495-504.
14. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C, Nishizawa N, Murosaki S, Kurokawa T, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta. 1452:1999;25-35.
15. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T, Onda H, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem. 275:2000;21061-21067. This paper revealed differential affinity, efficacy and dissociation of two apelin isoforms (apelin-13 and -36) with the APJ receptor, suggesting divergent functions of the two isoforms in vitro and in vivo.
16. Minami S, Nakata T, Tokita R, Onodera H, Imaki J. Cellular localization of prolactin-releasing peptide messenger RNA in the rat brain. Neurosci Lett. 266:1999;73-75.
17. Morales T, Hinuma S, Sawchenko PE. Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurones. J Neuroendocrinol. 12:2000;131-140.
18. Matsumoto H, Noguchi J, Horikoshi Y, Kawamata Y, Kitada C, Hinuma S, Onda H, Nishimura O, Fujino M. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun. 259:1999;321-324.
19. Jarry H, Heuer H, Schomburg L, Bauer K. Prolactin-releasing peptides do not stimulate prolactin release in vivo. Neuroendocrinology. 71:2000;262-267.
20. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Hinuma S, Onda H, Nishimura O, Fujino M, Higuchi T, et al. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Neurosci Lett. 276:1999;193-196.
21. Seal LJ, Small CJ, Kim MS, Stanley SA, Taheri S, Ghatei MA, Bloom SR. Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. Endocrinology. 141:2000;1909-1912.
22. Matsumoto H, Maruyama M, Noguchi J, Horikoshi Y, Fujiwara K, Kitada C, Hinuma S, Onda H, Nishimura O, Inoue K, et al. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett. 285:2000;234-238.
23. Lawrence CB, Celsi F, Brennand J, Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat Neurosci. 3:2000;645-646.
24. Parker R, Liu M, Eyre HJ, Copeland NG, Gilbert DJ, Crawford J, Sutherland GR, Jenkins NA, Herzog H. Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6. Biochim Biophys Acta. 1491:2000;369-375.
25. Ohtaki T, Kumano S, Ishibashi Y, Ogi K, Matsui H, Harada M, Kitada C, Kurokawa T, Onda H, Fujino M. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J Biol Chem. 274:1999;37041-37045.
26. Saeki Y, Ueno S, Mizuno R, Nishimura T, Fujimura H, Nagai Y, Yanagihara T. Molecular cloning of a novel putative G protein-coupled receptor (GPCR21) which is expressed predominantly in mouse central nervous system. FEBS Lett. 336:1993;317-322.
27. Eidne KA, Zabavnik J, Peters T, Yoshida S, Anderson L, Taylor PL. Cloning, sequencing and tissue distribution of a candidate G protein-coupled receptor from rat pituitary gland. FEBS Lett. 292:1991;243-248.
28. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G-protein-coupled receptor. J Biol Chem. 275:2000;25965-25971.
29. Calo G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol. 129:2000;1261-1283.
30. Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 23:2000;359-365.
31. Lynch KR, Im DS. Life on the edg. Trends Pharmacol Sci. 20:1999;473-475.
32. Xu Y, Zhu K, Hong G, Wu W, Baudhuin LM, Xiao Y, Damron DS. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol. 2:2000;261-267.
33. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, et al. A G protein-coupled receptor for UDP-glucose. J Biol Chem. 275:2000;10767-10771.
34. Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, Jenkins N, Copeland NG, Gilbert DJ, Nguyen N, et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem. 275:2000;22313-22323.
35. Jarmin DI, Rits M, Bota D, Gerard NP, Graham GJ, Clark-Lewis I, Gerard C. Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine Eskine. J Immunol. 164:2000;3460-3464.
36. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Muller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol. 164:2000;3465-3470.
37. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 399:1999;789-793.
38. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, et al. Characterization of the human cysteinyl leukotriene 2 (CysLT2) receptor. J Biol Chem. 275:2000;30531-30536. Capitalizingon the recent cloning of the novel CysLT1 receptor, these authors sought to isolate the pharmacologically recognized but previously uncloned CysLT2 receptor. Utilizing the CysLT1 receptor sequence, a search of the GenBank database revealed an EST fragment subsequently determined to encode the CysLT2 receptor.
39. Hosoda H, Kojima M, Matsuo H, Kangawa K. Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem. 275:2000;21995-22000.
40. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660.
41. Schweickart VL, Epp A, Raport CJ, Gray PW. CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines. J Biol Chem. 275:2000;9550-9556.
42. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, Austin CP, Figueroa D, MacNeil D, Cascieri MA, et al. Receptor for motilin identified in the human gastrointestinal system. Science. 284:1999;2184-2188.
43. Hedrick JA, Morse K, Shan L, Qiao X, Pang L, Wang S, Laz T, Gustafson EL, Bayne M, Monsma FJ Jr. Identification of a human gastrointestinaltract and immune system receptor for the peptide neuromedin U. Mol Pharmacol. 58:2000;870-875.
44. Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW, Zhou S, Kouranova EV, Nagorny R, Guevarra MS, et al. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem. 275:2000;32452-32459. One of four papers that detail the identification of neuromedin U as the endogenous ligand for the NMU1 receptor, these authors also simultaneously discovered a second neuromedin U receptor, NMU2, by searching the GenBank EST database. Such rapid elucidation of receptor subtypes can greatly facilitate the prompt characterization of novel ligand/receptor systems.
45. Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Habata Y, Hinuma S, Onda H, Nishimura O, Fujino M. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J Biol Chem. 275:2000;21068-21074.
46. Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GI, Murdock PR, Fitzgerald LR, Wu H, et al. Neuromedin U is a potent agonist at the orphan G protein coupled receptor FM3. J Biol Chem. 275:2000;20247-20250.
47. Im DS, Heise CE, Ancellin N, O'Dowd BF, Shei GJ, Heavens RP, Rigby MR, Hla T, Mandala S, McAllister G, et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem. 275:2000;14281-14286.
48. Van Brocklyn JR, Graler MH, Bernhardt G, Hobson JP, Lipp M, Spiegel S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood. 95:2000;2624-2629.
49. Mizushima K, Miyamoto Y, Tsukahara F, Hirai M, Sakaki Y, Ito T. A novel G-protein-coupled receptor gene expressed in striatum. Genomics. 69:2000;314-321.
50. Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K, Terao Y, et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol. 2:2000;703-708.